Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 19, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source
Showing the last 5 quarters. 54 more quarters, back to Mar 2012, with Tormere Pro.
Informational purposes only, not investment advice.
EDVA (EDVA)
tormere.com/research/EDVA · generated 2026-11-04
$0.18
+2.63%
General Information
Price$0.18
Change+2.63%
Market Cap—
Sector—
Industry—
Exchange—
Beta (raw, 60mo vs SPY)-1.16
Signals
Insider Velocity—
Congress Trades (90d)—
Short Volume
—
Conviction Score—
Price Chart (1 Year)
Recent News
Endovia Health Sciences Files Prospectus Related To Potential Resale Of Up To 1,013,041 Shares Of Common Stock By Selling Stockholder — Benzinga · 2026-10-27
Endovia Health Sciences, Inc. Estimates – AMEX:EDVA — TradingView · 2026-10-23
Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway — Yahoo · 2026-10-05
Endovia Health Sciences And Lupvindol BioSciences Receives FDA Determination That Proposed Use Of Cannepi For Control Of Pain Associated With Bone Cancer In Dogs Qualifies As 'Minor Use' — Benzinga · 2026-10-05
Tormere — informational purposes only, not investment advice.